ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,996Medicare Part D Prescriptions Filled, Including Refills

Rank: 159 out of 783

$525K Total Retail Price of All Prescriptions

Rank: 241 out of 783

524 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 524 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 9,783 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 582 482 S3 1 2
LISINOPRIL 476 425 2 4
FUROSEMIDE 383 354 3 7
SIMVASTATIN 381 340 4 3
LEVOTHYROXINE SODIUM 361 345 5 1
PREDNISONE 271 246 6 36
POTASSIUM CHLORIDE 266 245 7 16
METOPROLOL TARTRATE 262 249 8 9
HYDROCHLOROTHIAZIDE 214 202 9 12
OMEPRAZOLE 213 184 10 6
MELOXICAM 212 200 11 37
ATENOLOL 203 195 12 17
GABAPENTIN 191 167 13 15
CITALOPRAM HBR 182 159 14 19
AMLODIPINE BESYLATE 170 169 15 5
OXYCODONE HCL-ACETAMINOPHEN 169 111 S2 16 86
METFORMIN HCL 168 137 17 8
CIPROFLOXACIN HCL 164 154 18 62
TAMSULOSIN HCL 164 157 18 26
METOPROLOL SUCCINATE 148 130 20 13
METOLAZONE 115 92 21 186
ALLOPURINOL 109 102 22 31
WARFARIN SODIUM 108 97 23 10
AMILORIDE-HYDROCHLOROTHIAZIDE 101 100 24 264
AZITHROMYCIN 96 82 25 41
VERAPAMIL ER 94 94 26 119
CLOPIDOGREL 94 87 26 29
CARVEDILOL 88 73 28 21
GLIPIZIDE 78 66 29 71
TRAMADOL HCL 77 68 30 20
CLONIDINE HCL 76 67 31 60
FENTANYL 75 39 S2 32 65
OXYCONTIN 73 20 S2 33 171
SPIRONOLACTONE 69 61 34 57
RANITIDINE HCL 66 63 35 44
ALENDRONATE SODIUM 65 60 36 25
PLAVIX 65 53 36 51
SYNTHROID 60 60 38 47
PROAIR HFA 59 50 39 56
KLOR-CON 10 59 59 39 102
CRESTOR 59 59 39 27
LANTUS 57 40 42 38
GLIPIZIDE ER 56 48 43 84
PANTOPRAZOLE SODIUM 52 46 44 30
ZOLPIDEM TARTRATE 52 38 44 23
PRAVASTATIN SODIUM 51 38 46 14
KLOR-CON M20 50 36 47 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.